Literature DB >> 17621367

Leukaemogenic mechanism of human T-cell leukaemia virus type I.

Jun-ichirou Yasunaga1, Masao Matsuoka.   

Abstract

Adult T-cell leukaemia (ATL) is a neoplastic disease derived from CD4(+) T-lymphocytes and etiologically associated with human T-cell leukaemia virus type I (HTLV-I). In addition to structural genes, HTLV-I encodes regulatory and accessory genes in the pX region. Among them, Tax is thought to play a central role in leukaemogenesis through its potent transforming activity. However, since Tax is a major target of the host immune system, its expression is often lost in ATL cells, indicating Tax is dispensable in the last phase of leukaemogenesis. The HTLV-I bZIP factor (HBZ), encoded on the HTLV-I minus strand, was recently shown to be expressed in all ATL cells, and to support growth of human T-cell lines. These findings suggest that HBZ is critical to ATL onset. In addition to viral factors and genetic and epigenetic changes in cellular genes, the host immune status and genetic background also function in leukaemogenesis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17621367     DOI: 10.1002/rmv.548

Source DB:  PubMed          Journal:  Rev Med Virol        ISSN: 1052-9276            Impact factor:   6.989


  18 in total

1.  Mouse models of human T lymphotropic virus type-1-associated adult T-cell leukemia/lymphoma.

Authors:  B Zimmerman; S Niewiesk; M D Lairmore
Journal:  Vet Pathol       Date:  2010-05-04       Impact factor: 2.221

2.  CADM1 interacts with Tiam1 and promotes invasive phenotype of human T-cell leukemia virus type I-transformed cells and adult T-cell leukemia cells.

Authors:  Mari Masuda; Tomoko Maruyama; Tsutomu Ohta; Akihiko Ito; Tomayoshi Hayashi; Kunihiko Tsukasaki; Shimeru Kamihira; Shoji Yamaoka; Hiroo Hoshino; Teruhiko Yoshida; Toshiki Watanabe; Eric J Stanbridge; Yoshinori Murakami
Journal:  J Biol Chem       Date:  2010-03-09       Impact factor: 5.157

3.  MAGI-1 expression is decreased in several types of human T-cell leukemia cell lines, including adult T-cell leukemia.

Authors:  Takashi Kozakai; Masahiko Takahashi; Masaya Higuchi; Toshifumi Hara; Kousuke Saito; Yuetsu Tanaka; Masayoshi Masuko; Jun Takizawa; Hirohito Sone; Masahiro Fujii
Journal:  Int J Hematol       Date:  2017-10-17       Impact factor: 2.490

Review 4.  Human T-cell leukemia virus type 1 (HTLV-1) and leukemic transformation: viral infectivity, Tax, HBZ and therapy.

Authors:  M Matsuoka; K-T Jeang
Journal:  Oncogene       Date:  2010-11-29       Impact factor: 9.867

Review 5.  Why do viruses cause cancer? Highlights of the first century of human tumour virology.

Authors:  Patrick S Moore; Yuan Chang
Journal:  Nat Rev Cancer       Date:  2010-11-24       Impact factor: 60.716

6.  Absence of gain-of-function JAK1 and JAK3 mutations in adult T cell leukemia/lymphoma.

Authors:  T Kameda; K Shide; H K Shimoda; T Hidaka; Y Kubuki; K Katayose; Y Taniguchi; M Sekine; A Kamiunntenn; K Maeda; K Nagata; T Matsunaga; K Shimoda
Journal:  Int J Hematol       Date:  2010-08-10       Impact factor: 2.490

7.  Adhesion-dependent growth of primary adult T cell leukemia cells with down-regulation of HTLV-I p40Tax protein: a novel in vitro model of the growth of acute ATL cells.

Authors:  Kazuhiro Nagai; Itsuro Jinnai; Tomoko Hata; Tetsuya Usui; Daisuke Sasaki; Kunihiro Tsukasaki; Kazuyuki Sugahara; Yoshitaka Hishikawa; Yasuaki Yamada; Yuetsu Tanaka; Takehiko Koji; Hiroyuki Mano; Shimeru Kamihira; Masao Tomonaga
Journal:  Int J Hematol       Date:  2008-12-02       Impact factor: 2.490

8.  Liposomes and nanotechnology in drug development: focus on oncotargets.

Authors:  Tomohiro Kozako; Naomichi Arima; Makoto Yoshimitsu; Shin-Ichro Honda; Shinji Soeda
Journal:  Int J Nanomedicine       Date:  2012-09-14

Review 9.  Molecular determinants of human T-lymphotropic virus type 1 transmission and spread.

Authors:  Michael D Lairmore; Rajaneesh Anupam; Nadine Bowden; Robyn Haines; Rashade A H Haynes; Lee Ratner; Patrick L Green
Journal:  Viruses       Date:  2011-07-12       Impact factor: 5.048

10.  View and review on viral oncology research.

Authors:  Valeria Bergonzini; Cristiano Salata; Arianna Calistri; Cristina Parolin; Giorgio Palù
Journal:  Infect Agent Cancer       Date:  2010-05-24       Impact factor: 2.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.